PHA Classroom

Drug Development, Treatments on the Horizon and Stem Cells

March 2, 2017

During this session, the panel provides an overview of how drugs are developed and how newer drugs may impact drug selection, as well as various active and recently completed clinical trials.

Kelly Chin, MD, UT Southwestern
Patricia George, MD,, UPMC
Vallerie McLaughlin, MD, University of Michigan

Platinum Sponsor

Diamond Sponsor

This is a program of the PHA Connects Fund.